Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial

Annals of Oncology

Volumn 23, Issue 10, 2012, Pages 2591-2598

  Immink, J M ^a   Putter, H ^b   Bartelink, H ^c   Cardoso, J S ^d   Cardoso, M J ^e   Van der Hulst Vijgen, M H V ^f   Noordijk, E M ^b   Poortmans, P M ^f   Rodenhuis, C C ^g   Struikmans, H ^b,h  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY OF PORTO   (Portugal)

^e Champalimaud Cancer Center   (Portugal)

^f Institute Verbeeten   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h Radiotherapy Centre West   (Netherlands)

Author keywords

Boost; Breast cancer; Breast conserving therapy; Cosmetic results; Radiotherapy

Indexed keywords

TAMOXIFEN;

AGE; ARTICLE; BREAST CANCER; BREAST FIBROSIS; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; TUMOR LOCALIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL;

EID: 84867137599     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds066     Document Type: Article

References (49)

1. Fisher B, Anderson S, Bryant J et al. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16): 1233-1241.
2. Veronesi U, Cascinelli N, Mariani L et al. Twenty year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347(16): 1227-1232.
3. Van Dongen JA, Voogd AC, Fentiman IS et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92(14): 1143-1150.
4. Blichert-Toft M, Rose C, Andersen JA et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 199211): 19-25.
5. Jacobson JA, Danforth DN, Cowan KH et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332(14): 907-911.
6. Sarrazin D, Le MG, Arriagada R et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989; 14(3): 177-184.
7. Fisher B, Wickerham DL, Deutsch M et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol 1992; 8(3): 153-160.
8. Bartelink H, Horiot JC, Poortmans PM et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25(22): 3259-3265.
9. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345(19): 1378-1387.
10. Vrieling C, Collette L, Fourquet A et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost trial'. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 2000; 55(3): 219-232.
11. Vrieling C, Collette L, Fourquet A et al. The influence of the boost in breastconserving therapy on cosmetic outcome in the EORTC" boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1999; 45(3): 677-685.
12. Vrieling C, Collette L, Bartelink E et al. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC" boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 1999; 45(3): 667-676.
13. Harris JR, Levene MB, Svensson G et al. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979; 5(2): 257-261.
14. Pezner RD, Patterson MP, Hill LR et al. Breast retraction assessment: an objective evaluation of cosmetic results of patients treated conservatively for breast cancer. Int J Radiat Oncol Biol Phys 1985; 11(3): 575-578.
15. Van Limbergen E, van der Schueren E, Van Tongelen K. Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol 1989; 16(3): 159-167.
16. Noguchi M, Miyazaki I. Breast conserving surgery and radiation in the treatment of operable breast cancer. Int Surg 1994; 79(2): 142-147.
17. Krishnan L, Stanton AL, Collins CA et al. Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breastconserving surgical procedures and radiotherapy. Cancer 2001; 91(12): 2282-2287.
18. Al-Ghazal SK, Blamey RW, Cosmetic assessment of breast-conserving surgery for primary breast cancer. Breast 1999; 8(4): 162-168.
19. Cardoso JS, Cardoso MJ. Towards an intelligent medical system for the aesthetic evaluation of breast cancer conservative treatment. Artif Intell Med 2007; 40(2): 115-126.
20. Cardoso JS, Pinto da Costa JF, Cardoso MJ. Modelling ordinal relations with SVMs: an application to objective aesthetic evaluation of breast cancer conservative treatment. Neural Netw 2005; 18(5-6): 808-817.
21. Cardoso MJ, Cardoso J, Amaral N et al. Turning subjective into objective: the BCCT. core software for evaluation of cosmetic results in breast cancer conservative treatment. Breast 2007; 16(5): 456-461.
22. Cardoso MJ, Cardoso J, Santos AC et al. Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 2007; 13(2): 140-146.
23. Poortmans PM, Ataman F, Davis JB et al. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period. Radiother Oncol 2005; 76(3): 278-284.
24. Ptaszynski AM, Van den Bogaert W, Horiot JC et al. Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation. Acta Oncol 1999; 38(Suppl 13):19-27.
25. Collette S, Collette L, Budiharto T et al. EORTC Radiation Oncology Group. Predictors of the risk of breast fibrosis at 10 years after breast conserving therapy for early breast cancer-a study based on the EORTC trial 22881-10882" boost versus no boost". Eur J Cancer 2008; 44(17): 2587-2599.
26. Poortmans P, Bartelink H, Horiot JC et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. Radiother Oncol 2004; 72(1): 25-33.
27. Toledano AH, Bollet MA, Fourquet A et al. Does concurrent radio chemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients and doctors views. Int J Radiat Oncol Biol Phys 2007; 68(1): 66-72.
28. Borger JH, Kemperman H, Smitt HS et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994; 30(5): 1073-1081.
29. Chie EK, Kim K, Noh DY et al. Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer. Tumori 2007; 93(6): 591-596.
30. Arenas M, Sabater S, Hernandez V et al. Cosmetic outcome of breast conservative treatment for early stage breast cancer. Clin Transl Oncol 2006; 8 (5): 334-338.
31. Johansen J, Overgaard J, Rose C et al. Cosmetic outcome and breast morbidity in breast-conserving treatment-results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol 2002; 41(4): 369-380.
32. Bayerl A, Frank D, Lenz A et al. [Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer]. Strahlenther Onkol 2001; 177(1): 25-32.
33. Moro G, Stasi M, Borca VC. Does concomitant chemo radiotherapy influence cosmetic outcome in conservative treatment of breast cancer? Tumori 1997; 83 (4): 743-747.
34. de la Rochedierre A, Abner AL, Silver B et al. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique?. Int J Radiat Oncol Biol Phys 1992; 23(5): 925-931.
35. Wazer DE, Morr J, Erban JK et al. The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 1997; 80(4): 732-740.
36. Dewar JA, Benhamou S, Benhamou E et al. Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers. Radiother Oncol 1988; 12(4): 273-280.
37. Steeves RA, Phromratanapongse P, Wolberg WH et al. Cosmesis and local control after irradiation in women treated conservatively for breast cancer. Arch Surg 1989; 124(12): 1369-1373.
38. Taylor ME, Perez CA, Halverson KJ et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995; 31(4): 753-764.
39. Touboul E, Belkacemi Y, Lefranc JP et al. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 1995; 34(2): 105-113.
40. Touboul E, Pene F, Blazska-Jaulerry B et al. Review of results and clinical analysis of conservative partial surgery associated with postoperative radiotherapy in operable breast cancers stages I and II. Bull Cancer 1992; 79(4): 315-346.
41. Antonini N, Jones H, Horiot JC et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007; 82(3): 265-271.
42. Vrieling C, Collette L, Fourquet A et al. Can patient-, treatment-and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer 2003; 39(7): 932-944.
43. Sackey H, Sandelin K, Frisell J et al. Ductal carcinoma in situ of the breast. Long-term follow-up health-related quality of life, emotional reactions and body image. Eur J Surg Oncol 2010; 36(8): 756-762.
44. Veiga DF, Veiga-Filho J, Ribeiro LM et al. Quality-of-life and self-esteem outcomes after oncoplastic conserving surgery. Plast Reconstr Surg 2010; 125 (3): 811-817.
45. Han J, Grothuesmann D, Neises M et al. Quality of life and satisfaction after breast cancer operation. Arch Gynecol Obstet 2010; 282(1): 75-82.
46. Montazeri A Health-related quality of live in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 2927-32.
47. Alcikus ZA, Gorken IB, Sen RC et al. Psychosexual and body image aspects of quality of life in Turkish breast cancer patients: a comparison of breast conserving treatment and mastectomy. Tumori 2009; 95(2): 212-218.
48. Ohsumi S, Shimozuma K, Morita S et al. Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery. Jpn J Clin Oncol 2009; 39(8): 491-496.
49. Arndt V, Stegmaier C, Ziegler H et al. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population based study. J Cancer Res Clin Oncol 2008; 134(12): 1311-1318.